is glp 1 banned by wada Ozempic On WADA's Monitoring List For 2025 2026 WADA Prohibited List Now

94% reduction in progression from pre diabetes to type 2 diabetes with tirzepatide.** **Based on a three-year clinical trial study (176-week treatment period) sponsored by Eli Lilly and Company, weekly injections of tirzepatide significantly reduced the risk of progression to type 2 diabetes by 94% in adults with prediabetes who were overweight or obese compared to placebo

The dramatic amount of weight that study volunteers lost on the new drug exceeds the percentage of weight most people lose when they use the popular weight-loss drugs, Wegovy and Zepbound

Among the remedies are a forthcoming Medicare-Medicaid program in which drug manufacturers may offer lower GLP-1 prices and weight-loss lifestyle interventions to some enrollees

Do you have more questions about GLP-1s

Recent Developments In February 2026 , Pfizer announced positive Phase 2b trial results for its ultra-long-acting injectable GLP-1 (PF-08653944), demonstrating significant weight loss with monthly dosing

This ingredient helps soothe redness and irritation, especially when combined with antioxidants and hydrating agents